Ilias Goranitis
Head, Economics of Genomics & Precision Medicine Unit, University of Melbourne | Health Economics Lead, Australian Genomics | Deputy Head, Melbourne Health Economics, Centre for Health Policy #HealthEconomics #Genomics
- Reposted by Ilias GoranitisHow can we measure the value of #genomics in #healthcare? How can #HTA, #implementation & data management be adapted to suit the rapidly evolving nature of genomics? For insights, read the Review from Zornitza Stark, Ilias Goranitis & colleagues. nature.com/articles/s41591-025…
- In this Nature Medicine paper, we draw from our experiences in evaluating and implementing #genomics in Australia, Canada, England, Hong Kong and the US www.nature.com/articles/s41...
- We discuss progress in measuring and valuing genomics, evidentiary and process challenges for HTA and practical solutions for policy decisions-making, implementing genomics to deliver value, life-cycle HTA and learning healthcare, broader macro-economic benefits.
- Reposted by Ilias GoranitisDetermining the value of genomics in healthcare” is now published in Nature Medicine. Led by A/Prof Ilias Goranitis, the paper brings together international co-authors to examine how the value of genomics can be assessed. Read the full article: www.nature.com/articles/s41...
- Reposted by Ilias Goranitiswww.nature.com/articles/s41... 🔥🔥🔥 Is genomics value for money??? 🧬💰 👉 How do we define it? 👉 Measure it? 👉 And deliver it? rdcu.be/eR243 @iliasgoranitis.bsky.social @stephaniebest.bsky.social @hadleyssmith.bsky.social @rich-genomics.bsky.social @jbuchanan-ox.bsky.social @rdexeter.bsky.social
- Reposted by Ilias Goranitis[Not loaded yet]
- Reposted by Ilias Goranitis🤗 Out now @naturemedicine.bsky.social results of our genomic NBS study BabyScreen+ 👶🧬 👉 www.nature.com/articles/s41... 1,000 babies WGS using existing cards 600+ conditions 13 day TAT 16 diagnoses (vs 1 in std NBS) High clinical impact High parental acceptability
- Help us develop a roadmap for stakeholders to consider when integrating #healtheconomics alongside #genomics to inform decision-making. Please share your local perspectives on challenges & opportunities of evaluating and implementing genomics q.surveys.unimelb.edu.au/jfe/form/SV_...
- Wonderful to see our paper on the #Value and #Implementation of #Genomic_Newborn_Screening published in @ajhgnews.bsky.social #BabyScreen+ #HealthEconomics #DCE
- 📣New today! 📄Public preferences for the value and implementation of genomic newborn screening: Insights from two discrete choice experiments in Australia 🧑🤝🧑 @iliasgoranitis.bsky.social @zornitza.bsky.social & co
- Reposted by Ilias GoranitisWhat does the Australian public think about the value and implementation of genomic NBS? 🧬👶⚖️ @ajhgnews.bsky.social @iliasgoranitis.bsky.social @stephaniebest.bsky.social @genomeseb.bsky.social @genetic-fi.bsky.social #raredisease #genomics #healtheconomics www.sciencedirect.com/science/arti...
- Reposted by Ilias Goranitis[Not loaded yet]
- A must-read: The Cost-Effectiveness of #Genomic_Medicine in #Cancer Control: A Systematic Literature Review link.springer.com/article/10.1... Grateful to the @who.int and Cancer Australia for their support.
- Reposted by Ilias GoranitisAs @ausgenomics.bsky.social comes to an end: what have we learned? 🇦🇺🧬 @naturemedicine.bsky.social 👉 rdcu.be/eeuAN Change is hard! Key for success: working across disciplines; jurisdictions; and all leadership levels🏆 @stephaniebest.bsky.social @iliasgoranitis.bsky.social @andrewmallett8.bsky.social
- Reposted by Ilias Goranitis[Not loaded yet]
- Reposted by Ilias GoranitisWhat happens when #genomic testing is funded?🧬 👉 rdcu.be/d8MSL Last 10yrs 🇦🇺: Many tests approved as evidence grows ✅ BUT testing volumes low AND inequitable access Budget impact of #genomics minor: AU$3Mpa or <0.01% of all health expenditure 💰 @ausgenomics.bsky.social @iliasgoranitis.bsky.social
- New paper in the European Journal of Human Genetics: Utilisation of subsidised genetic and genomic testing in Australia during 2014–2023 www.nature.com/articles/s41...
- @CancerAustralia has now launched the National Framework for Genomics in Cancer Control. www.canceraustralia.gov.au/key-initiati... It was an honor to lead the #healtheconomics component of the evidence review that informed the development of this framework. Access it through link ⬇️
- Reposted by Ilias Goranitis[Not loaded yet]
- GUV-scale New way to measure & score genomic utility on a 0-100% scale based on 5 policy priority indicators (clinical, diagnostic, economic, societal, and family utility) doi.org/10.1016/j.jv... @zornitza.bsky.social @stephaniebest.bsky.social @andrewmallett8.bsky.social @ausgenomics.bsky.social
- New role within our Economics of Genomics & Precision Medicine Unit - Applications deadline Jan 20 #healtheconomics jobs.unimelb.edu.au/caw/en/job/9...
- Honoured to receive a Dame Kate Campbell Fellowship and join excellent colleagues in the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne who have inspired me with their work over the years!
- An important step towards the economic evaluation of #FunctionalGenomics! A #MicroCosting of mass-spectrometry based quantitative #Proteomics url.au.m.mimecastprotect.com/s/TeIxCxnMJ5... @ausgenomics.bsky.social
- Economics of Genomics and Precision Medicine Unit Strategy Day reflections and fun - So proud of the personal & professional qualities of my team #HealthEconomics #Genomics
